Bio-Tissue, a business unit of TissueTech, announced a new Prokera Medical Coding and Compliance Guide is now available for practitioners. The new guide will be introduced and available at the upcoming American Academy of Optometry’s annual meeting, taking place October 11-14, 2017 in Chicago.
“Our company is dedicated to supporting customers with the successful implementation of our technologies in eye care practices throughout the world, and coupled with quality of care, reimbursement is paramount to this success,” Thomas G. Daniells, Chief Commercial Officer, Bio-Tissue, said in a company news release. “We developed this comprehensive guide to provide all of the information needed for our practices to succeed clinically, as well as financially.”
John Rumpakis, OD, MBA, a leading authority on medical coding and compliance issues in eye care, developed the Prokera Medical Coding and Compliance Guide, which provides practitioners with all of the information needed for medical coding and billing of Prokera. This includes: medical necessity and importance, ocular use and approval, MIPS and the health economics of Prokera, considerations for insurance companies and Medicare, modifiers and their use, valuable reference material, and more.
“Our healthcare system is quickly changing and transitioning toward an outcomes based payment system, so it’s important for eye care practitioners to have all of the information needed to successfully manage their patients’ treatment in an efficient and effective manner, and still ultimately be profitable,” John Rumpakis, OD, MBA, President and Chief Executive Officer, Practice Resource Management, said in the news release. “As ocular surface disease becomes a bigger part of the optometric practice of managing chronic disease, it’s important for clinicians to have all the tools they need to properly manage patients. That means they need to know what to use and when to use it, as they approach employing the best technology available. Having the best tools at their disposal when a clinical case calls for a particular approach, will greatly aid the practitioner in developing treatment plans that provide better clinical outcomes.”
Eye doctors around the world use Prokera biologic corneal bandage devices for healing and treating corneal involved dry eye, keratitis, recurrent corneal erosions and other ocular surface diseases. Prokera is the only therapeutic device cleared by the FDA that simultaneously reduces inflammation and promotes regenerative healing of the ocular surface.
Dr. Rumpakis will speak about the Prokera Medical Coding Compliance Guide at Bio-Tissue’s booth #403 at the Academy of Optometry’s annual meeting. In addition to Dr. Rumpakis, distinguished speakers will discuss the clinical aspects of Prokera and Cliradex, and conduct live product demonstrations.
Bio-Tissue’s Academy 2017 Booth Speaker Schedule
WEDNESDAY, OCTOBER 11
Jeffrey Sonsino, OD, Clinical Aspects of PROKERA and Cliradex, 5 p.m.
Moshe Schwartz, OD, PROKERA and Cliradex Demonstrations, 6 p.m.
THURSDAY, OCTOBER 12
Scott Schachter, OD, PROKERA and Cliradex Demonstrations, 12:30 p.m.
John Rumpakis, OD, MBA, PROKERA Reimbursement, 1 p.m.
Marc Bloomenstein, OD, PROKERA and Cliradex Demonstrations, 5 p.m.
FRIDAY, OCTOBER 13
John Rumpakis, OD, MBA, PROKERA Reimbursement, 12 p.m.
Walt Whitley, OD, PROKERA and Cliradex Demonstrations, 1:30 p.m.